• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

The Dawn of the Intelligence Age: How AI is Transforming Science and Medicine

user avatar

by Giorgi Kostiuk

2 years ago


On September 23, Sam Altman, co-founder and CEO of OpenAI, released an essay declaring the arrival of the “Intelligence Age.” Altman claims that AI will lead to exponential advancements including climate solutions and discoveries in physics. Despite criticism, AI is already being utilized in various scientific fields and medicine, accelerating research and improving healthcare services.

Artificial Intelligence in Ultrasound Imaging

GE Verisound AI employs proprietary software to assist non-experts in capturing high-quality ultrasound images of the heart, aiding in earlier disease detection. One of the company's main offerings, Caption AI, provides real-time visual guidance and quality measurement to ensure high-resolution images. The AutoEF feature, driven by AI algorithms, calculates critical heart health metrics such as the left ventricular ejection fraction.

AI in Drug Discovery

San Francisco-based Atomwise uses AI to accelerate the drug discovery process. Their AtomNet platform utilizes convolutional neural networks to predict the efficacy of potential drug candidates before costly clinical trials. By analyzing experimental affinity measurements and protein structures, AtomNet speeds up the identification of safe and effective drug candidates, significantly reducing the time and cost of bringing new medicines to market. In April 2024, Atomwise successfully identified novel drug candidates for 235 out of 318 targets.

The Role of AI in Radiology

Behold.ai is developing AI-assisted radiology with its “red dot” algorithm, which classifies chest X-rays and localizes findings as heat maps using deep learning models. The algorithm achieves 90% accuracy in detecting abnormalities within seconds, reducing radiologists' workloads and diagnosis wait times. Similarly, Enlitic uses deep learning to interpret medical images, enabling the detection of malignant lung nodules up to 18 months before a biopsy.

AI is playing a significant role in scientific research and medical advancements. Its applications, from ultrasound imaging to drug discovery and medical image interpretation, highlight its tremendous potential to improve healthcare and accelerate scientific progress.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Bybit Introduces RWA Earn Portal for Tokenized Yield Access

chest

Bybit has launched the RWA Earn portal, enabling eligible users to access tokenized yield products, marking a shift in how exchanges operate.

user avatarElias Mukuru

Investment Opportunities in AI Stocks

chest

Investors are encouraged to consider Nvidia and Micron Technologies for their potential growth in the AI sector.

user avatarKenji Takahashi

Understanding the Risks of Synthetic Perpetual Markets

chest

Traders in synthetic perpetual markets must be aware of the risks associated with derivatives trading, including lack of ownership and potential price volatility.

user avatarMaria Fernandez

Hyperliquids SPCX Perpetual Market Offers Flexible Trading Options

chest

Hyperliquids SPCX perpetual market offers a synthetic trading alternative to tokenized SpaceX allocations, enabling traders to speculate without physical asset delivery.

user avatarGustavo Mendoza

SpaceX Tokenized Share Campaign Faces Refund Issues

chest

A tokenized SpaceX share campaign has been canceled, leading to refunds and highlighting challenges in sourcing underlying shares.

user avatarRajesh Kumar

Kraken to Introduce CFTC-Regulated Perpetual Futures for US Traders.

chest

Kraken is set to introduce CFTC-regulated perpetual futures for eligible US professional traders through its acquisition of Bitnomial.

user avatarMiguel Rodriguez

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.